BACKGROUND: A downturn in breast cancer (BC) incidence among Spanish women has been recently reported and attributed to screening saturation. This article analyses BC trends and their relationship with the introduction of the screening programme in all Spanish regions having available information. MATERIAL AND METHODS: The study covers the period 1980-2004. All Spanish population-based cancer registries with 10 years of uninterrupted registration furnished data on invasive BC. Trends in BC incidence among women aged <45 years and among those aged > or =45 years were assessed using Poisson transition models to estimate the existence of a change-point in the overall trend. Furthermore, in those regions that had registered BC incidence before implementing the screening programme, the annual percentage change in women aged > or =45 years was computed before screening, during the first round of screening and after full coverage had been achieved. RESULTS: The study included 82 699 incident cases. Whereas BC increased during the 1980s and 1990s, from 2001 onwards a decline was observed among women aged > or =45 years. This phenomenon was clearly visible in regions that had implemented BC screening before 2000 and attained high participation rates. In such areas, BC incidence rose sharply during screening implementation, with an overall increase of approximately 20%-30%. BC incidence fell once full coverage was achieved and tended to level off or even increase thereafter, as was the case in Navarre. In women aged <45 years, BC increased by 1.7% per annum across the period. CONCLUSIONS: Screening has strongly influenced recent BC trends among Spanish women aged > or =45 years. Our results support the influence of screening saturation on the recent decline of BC. Among younger women, incidence is still rising, probably reflecting the lifestyle changes observed in younger generations.
BACKGROUND: A downturn in breast cancer (BC) incidence among Spanish women has been recently reported and attributed to screening saturation. This article analyses BC trends and their relationship with the introduction of the screening programme in all Spanish regions having available information. MATERIAL AND METHODS: The study covers the period 1980-2004. All Spanish population-based cancer registries with 10 years of uninterrupted registration furnished data on invasive BC. Trends in BC incidence among women aged <45 years and among those aged > or =45 years were assessed using Poisson transition models to estimate the existence of a change-point in the overall trend. Furthermore, in those regions that had registered BC incidence before implementing the screening programme, the annual percentage change in women aged > or =45 years was computed before screening, during the first round of screening and after full coverage had been achieved. RESULTS: The study included 82 699 incident cases. Whereas BC increased during the 1980s and 1990s, from 2001 onwards a decline was observed among women aged > or =45 years. This phenomenon was clearly visible in regions that had implemented BC screening before 2000 and attained high participation rates. In such areas, BC incidence rose sharply during screening implementation, with an overall increase of approximately 20%-30%. BC incidence fell once full coverage was achieved and tended to level off or even increase thereafter, as was the case in Navarre. In women aged <45 years, BC increased by 1.7% per annum across the period. CONCLUSIONS: Screening has strongly influenced recent BC trends among Spanish women aged > or =45 years. Our results support the influence of screening saturation on the recent decline of BC. Among younger women, incidence is still rising, probably reflecting the lifestyle changes observed in younger generations.
Authors: J Galceran; A Ameijide; M Carulla; A Mateos; J R Quirós; D Rojas; A Alemán; A Torrella; M Chico; M Vicente; J M Díaz; N Larrañaga; R Marcos-Gragera; M J Sánchez; J Perucha; P Franch; C Navarro; E Ardanaz; J Bigorra; P Rodrigo; R Peris Bonet Journal: Clin Transl Oncol Date: 2017-01-16 Impact factor: 3.405
Authors: Nora Eisemann; Annika Waldmann; Alan C Geller; Martin A Weinstock; Beate Volkmer; Ruediger Greinert; Eckhard W Breitbart; Alexander Katalinic Journal: J Invest Dermatol Date: 2013-07-22 Impact factor: 8.551
Authors: A Waldmann; S Nolte; M A Weinstock; E W Breitbart; N Eisemann; A C Geller; R Greinert; B Volkmer; A Katalinic Journal: Br J Cancer Date: 2012-01-31 Impact factor: 7.640
Authors: Montserrat Solá; Mireia Margelí; Eva Castellá; Juan F Julian; Miquel Rull; Josep M Gubern; Antonio Mariscal; Agustí Barnadas; Manuel Fraile Journal: BMC Cancer Date: 2011-06-16 Impact factor: 4.430
Authors: T M Ripping; A L M Verbeek; D van der Waal; J D M Otten; G J den Heeten; J Fracheboud; H J de Koning; M J M Broeders Journal: Br J Cancer Date: 2013-10-10 Impact factor: 7.640
Authors: Marina Pollán; Nieves Ascunce; María Ederra; Alberto Murillo; Nieves Erdozáin; Jose Alés-Martínez; Roberto Pastor-Barriuso Journal: Breast Cancer Res Date: 2013-01-29 Impact factor: 6.466
Authors: Josep M Escribà; Laura Pareja; Laura Esteban; Jordi Gálvez; Angels Melià; Laura Roca; Ramon Clèries; Xavier Sanz; Montse Bustins; María J Pla; Miguel J Gil; Josep M Borrás; Josepa Ribes Journal: BMC Res Notes Date: 2014-09-01